Pivotal trial found the enfortumab vedotin plus pembrolizumab combination significantly extended overall and progression-free survival
An accomplished R&D leader and champion of the application of AI to drug discovery
NEIAFMR to be developed as the national hub for folk medicine
Funding round led by Sarissa Capital, includes Sun Pharma, Polaris Partners
Receives registration of Valganciclovir powder for oral solution in Germany
The initiation of the second clinical trial in the INTerpath program represents rapid expansion in research for additional tumor types for individualized neoantigen therapy, V940 (mRNA-4157)
High-quality baobab oil sourced in collaboration with UNCCD and the Great Green Wall Initiative
Equipped with most advanced Distributed Control System (DCS) automation technology, the facility has been set up with an investment of Rs. 200 crore
The collaboration brings a seamless digital experience to more formulators worldwide
The drug will be marketed by Sun Pharma under the brand name RYTSTAT
Subscribe To Our Newsletter & Stay Updated
